# Qijia Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qijia-technology

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou Industrial Park, China
- Latest round: Angel (Nov 27, 2023)
- Investors on record: 1

## About

Established in 2022 and based in Suzhou, China, Qijia Technology operates as a medical company dedicated to researching and developing 3D bionic microorganisms. The company has been authorized for nearly twenty invention patents. In November 2023, it raised angel funding led by new investor Kexun Ruijin Capital. 

The company mainly produces human-derived bionic microorganisms of the lung, liver, pancreas, and duodenum. It also provides colorectum products such as test kits, supporting reagents, and microorganisms. The company also provides iPS lineage co-differentiation technology, and customized services in the fields of scientific research, drug development, and precision medicine.

## Funding rounds

- Angel, Nov 27, 2023 — Kexun Ruijin Capital

## Investors

- Kexun Ruijin Capital (https://capitalatlas.ai/funds/kexun-ruijin-capital) — Angel